Effects of Kangaroo Care on Infants After Heart Surgery
The Effect of Kangaroo Care on Vital Signs of Infants After Cardiac Surgery
This study is testing if skin-to-skin contact, known as kangaroo care, can help improve the health and comfort of infants after heart surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 1 Day to 30 Days |
| Sex | All |
| Sponsor | Istinye University Academic / other |
| Locations | 1 site (Istanbul, Zeytinburnu) |
| Trial ID | NCT06400446 on ClinicalTrials.gov |
What this trial studies
This study investigates how kangaroo care, which involves skin-to-skin contact between an infant and caregiver, affects the vital signs of infants undergoing cardiac surgery. The research aims to determine if kangaroo care can improve oxygen saturation, lower peak heart rates, reduce respiratory rates, stabilize arterial blood pressure, and decrease pain levels in these infants. By comparing infants who receive kangaroo care to those who do not, the study seeks to establish formal standards for implementing this low-cost, low-risk intervention in clinical practice.
Who should consider this trial
Good fit: Ideal candidates for this study are infants over 37 weeks gestational age who undergo cardiac surgery within the first 30 days of life and have closed chest incisions.
Not a fit: Infants with non-cardiac congenital defects or those who are intubated may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the physiological stability and comfort of infants recovering from cardiac surgery.
How similar studies have performed: While clinical studies on kangaroo care for infants undergoing cardiac surgery are limited, existing literature suggests positive outcomes from similar interventions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The gestational week of the infant is greater than 37 weeks * Cardiac surgery operation within the first 30 days of life * The infant's chest incision is closed Exclusion Criteria: * The infant has non-cardiac congenital defects or syndrome * Intubation of the infant
Where this trial is running
Istanbul, Zeytinburnu
- Selvinaz Albayrak — Istanbul, Zeytinburnu, Turkey (Recruiting)
Study contacts
- Principal investigator: Dilara Cengizli, Nurse — Istanbul Health Sciences University Mehmet Akif Ersoy Chest Heart and Vascular Surgery Training and Research Hospital Paediatric Cardiovascular Surgery Intensive Care Unit
- Study coordinator: Selvinaz Albayrak, Asst Prof
- Email: selvinaz.albayrak@istinye.edu.tr
- Phone: +905438708905
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.